We use cookies to provide you with a better experience. By continuing to browse the site you are agreeing to our use of cookies in accordance with our Cookie Policy.
Accept
  • SKIP TO CONTENT
  • SKIP NAVIGATION
  • Drug News
    • Trending
    • Commercial Operations
    • GMPs
    • FDA Enforcement Actions
    • Inspections and Audits
    • Postmarket Safety
    • Quality
    • Regulatory Affairs
    • Research and Development
    • Submissions and Approvals
    • FDAnews Drug Weekly
    • FDAnews
  • Device News
    • Trending
    • Commercial Operations
    • FDA Enforcement Actions
    • Inspections and Audits
    • Postmarket Safety
    • Quality
    • Regulatory Affairs
    • Research and Development
    • Submissions and Approvals
    • FDAnews Device Weekly
    • FDAnews
  • Books
    • FDAnews Books Library
    • Drug Books
    • Device Books
  • Training/Events
    • Webinar Training Pass
    • Events
  • Resources
    • Form 483s Database
    • FDA Approved Drugs
    • White Papers
  • CenterWatch
  • About Us
    • The Company
    • FDAnews Editorial Board
    • Contact Us
  • Advertising
  • Sign In
  • Create Account
  • Sign Out
  • My Account
Home » Newsletters » International Medical Device Regulatory Monitor

Our Publications

Please select a publication below.
International Medical Device Regulatory Monitor

International Medical Device Regulatory Monitor

December 2014

Vol.: 22
No. 12
  • Headlines

Headlines

Back to Top

Full Issue of International Medical Device Regulatory Monitor in PDF Format

December 16, 2014
Download and view the full issue. Read More

CDSCO, Industry Each Take Stab At Improving Quality of Devices

December 16, 2014
India’s Central Drug Standards Control Organization has issued a draft guideline on good manufacturing practices for medical devices and diagnostics — the latest in an effort to increase the quality of medtech products, which are governed loosely under the country’s drug laws. Read More

Canada’s New Product Safety Law Could Jeopardize Trade Secrets

December 16, 2014
A sweeping rewrite of Canada’s drug safety law that authorizes the government to order recalls and require labeling changes and postmarket studies could spell new worries for devicemakers because it also allows for the release of confidential business information on unsafe products. Read More

Panel Cites Lack of Safety Data on DEHP, Alternative Materials

December 16, 2014
The European Commission is again seeking to calculate the potential risks of the plasticizer di(2-ethylhexyl) phthalate in medical devices, saying there is a dearth of conclusive data to support limiting its use. Read More

UK Announces Major Review to Speed Devices to Market

December 16, 2014
The British government is conducting a massive review of how new medical devices and in vitro diagnostics are developed, with the aim of bringing products to market faster and speeding patient access. But some observers say the initiative should be broader and also include reforms in national reimbursement policy. Read More

Groups Push for More Harmonized Approach to Technology Assessments

December 16, 2014
A voluntary network of European health technology assessment bodies is calling for greater cooperation among HTAs to avoid duplicating work related to medical device coverage decisions in individual EU countries. Read More

Guidance Clarifies Notified Body Requirements for Device Changes

December 16, 2014
Changes to a medical device’s software, in most cases, require notified body review and acceptance prior to release in the European market to ensure the safety and wellbeing of patients and caregivers, according to best practice guidance developed by the European Commission. Read More

RoHS 2: One Company’s Efforts to Comply With New Rules

December 16, 2014
Three months after the EU’s RoHS 2 deadline, U.S. devicemaker Stryker has reviewed more than 600 products and dealt with “significant” costs to comply with the regulations. Despite the onerous mandate, the company says it has had a relatively easy time finding alternative components when needed. Read More

IMDRF Compiles List of Standards for Use as Harmonization Tool

December 16, 2014
The International Medical Device Regulators Forum has published a final report on international standards to be used by regulatory authorities in harmonizing regulatory requirements. Read More

Aussies, Kiwis Scrap Efforts on Joint Regulatory Agency

December 16, 2014
Australia and New Zealand have abandoned plans for a joint drugs and devices regulatory authority, although both countries say they will continue to cooperate on mutually beneficial regulations. Read More

China, U.S. to Cut Tariffs on IT Medical Devices

December 16, 2014
Import duties on a range of IT products, including some high-tech medical devices, would be eliminated under a breakthrough agreement reached Nov. 10 by China and the U.S. The agreement paves the way for World Trade Organization members to broker a similar deal across more markets. Read More

Class III, PMAs for Flexible Pedicle Screws Proposed in U.S.

December 16, 2014
The U.S. Food and Drug Administration plans to tighten restrictions on dozens of spinal screws already on the market, requiring new PMAs for dynamic stabilization systems that are used to treat severe spondylolisthesis, fracture, dislocation, scoliosis and spinal tumors. Read More

U.S. FDA Sees 15 Percent Bump in Regulatory Restrictions

December 16, 2014
U.S. Food and Drug Administration regulations have gotten lengthier and more prohibitive, with the number of regulatory restrictions up 15 percent since the turn of the century, new data show. Read More

Think Tank: U.S. FDA Off-Label Sharing Rules Too Restrictive

December 16, 2014
Recent U.S. Food and Drug Administration guidance on distributing scientific publications that cover off-label uses is out of touch with today’s data-driven economy and should be modified to embrace digital communication platforms, a Washington, D.C., think tank says. Read More

NICE Requests More Data on Two Skin Care Treatments in UK

December 16, 2014
The UK’s health cost-benefit watchdog says there is insufficient evidence on two promising new skin care technologies to justify their routine use. Read More

Brazil Clarifies Rules for Collaborative Development of ‘Strategic’ Devices

December 16, 2014
The Brazilian government is providing more clarity around a voluntary program that encourages public-private partnerships to expand access to affordable medical devices and diagnostics, but questions remain about the program’s transparency. Read More

In Brief

December 16, 2014

Upcoming Events

  • 28Sep

    The Cost of Counterfeiting: Why You Need a Plan to Secure Your Medical Device Supply Chain

  • 28Sep

    Calculating Sample Size to Satisfy FDA Expectations

  • 11Oct

    GMP Quality Management vSummit 2023: Where Quality Meets Risk

  • 16Oct

    MAGI@home Clinical Research Conference 2023

  • 26Oct

    FDA in 2024: What to Expect in an Election Year

  • 08Nov

    18th Annual FDA Inspections vSummit

Featured Products

  • FDA, FTC and DOJ Enforcement of Medical Device Regulations

    FDA, FTC and DOJ Enforcement of Medical Device Regulations

  • Using Real-World Evidence in Drug and Device Submissions

    Using Real-World Evidence in Drug and Device Submissions

Featured Stories

  • Top Concern for CBER is Marketing of Unapproved Biologics, Says FDA Official

  • FDA Deems Medline Industries’ Saline Solution Vial Recall as Class 1

  • FDA Adcomm Votes Down Intarcia’s T2 Diabetes Combo Product

  • Mixed Reality Neurosurgery Navigation and CAD Detection Systems Gets FDA Clearance

The Revised ICH E8: A Guide to New Clinical Trial Requirements

Learn More
  • Drug Products
    • Quality
    • Regulatory Affairs
    • GMPs
    • Inspections and Audits
    • Postmarket Safety
    • Submissions and Approvals
    • Research and Development
    • Commercial Operations
  • Device Products
    • Quality
    • Regulatory Affairs
    • QSR
    • Inspections and Audits
    • Postmarket Safety
    • Submissions and Approvals
    • Research and Development
    • Commercial Operations
  • Clinical Products
    • Trial Design
    • Data Integrity
    • GCP
    • Inspections and Audits
    • Transparency
  • Privacy Policy
  • Do Not Sell or Share My Data
Footer Logo

300 N. Washington St., Suite 200, Falls Church, VA 22046, USA

Phone 703.538.7600 – Toll free 888.838.5578

Copyright © 2023. All Rights Reserved. Design, CMS, Hosting & Web Development :: ePublishing